TXNIP and diabetes mellitus: Taken together, our studies support the hypothesis that drugs targeting stabilization of cellular calcium levels and suppression of TXNIP during pro-inflammatory cytokine stress can prevent beta cell death, thus establishing modulation of ER and cytosolic free calcium levels and TXNIP suppression as viable options to prevent cytokine-mediated beta cell loss in diabetes.